Global Cognitive Neuroscience Market Size, Share, and COVID-19 Impact Analysis, By Type (Magnetic Resonance Imaging (MRI), Functional Magnetic Resonance Imaging (fMRI), Positron Emission Tomography (PET), Magnetoencephalography (MEG), Encephalography (EEC), Near Infrared Spectroscopy (NIRS), and Single Photon Emission Computed Tomography (SPECT)), By Application (Brain Imaging, Neurological Research, Neurological Disorders and Psychiatry), By End User (Pharmaceutical Companies, Clinical & Research Laboratories, Academic Research Institutes, Hospitals & Pathology Laboratories and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Global Cognitive Neuroscience Market Insights Forecasts to 2035

• The Global Cognitive Neuroscience Market Size Was Estimated at USD 37.58 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of around 6.56% from 2025 to 2035
• The Worldwide Cognitive Neuroscience Market Size is Expected to Reach USD 75.63 Billion by 2035
• Asia Pacific is expected to grow the fastest during the forecast period.

According to a research report published by Spherical Insights and Consulting, the global cognitive neuroscience market size was worth around USD 37.58 billion in 2024 and is predicted to grow to around USD 75.63 billion by 2035 with a compound annual growth rate (CAGR) of 6.56% from 2025 to 2035. The growing cases of neurological disorders, advancements in neuroimaging and the integration of AI within them, funding for more research, and applications in mental health, neurodegenerative diseases, and brain-computer interfaces are all pressing factors that drive innovation within diagnostics and the enhancement of cognitive performance.

Market Overview

The global cognitive neuroscience market refers to the scientific study of the brain functions related to cognition, including perception, memory, attention, decision-making, and language. Cognitive neuroscience combines psychology, neurology, and neurobiology using advanced technologies like fMRI, PET, EEG, and BCIs. Advanced technologies are applied across the board in clinical research, mental health diagnosis, the diagnosis of neurodegenerative diseases, the enhancement of cognitive performance, and the study of interactions between the brain and machines. Strong growth in neurological and psychiatric disorders, a growing geriatric population, and increasing demand for innovative diagnostic and therapeutic options are key factors driving market growth. Technological advancements such as AI-based neuroimaging analysis, high-resolution brain mapping, and real-time brain activity monitoring have helped to push the understanding of neural mechanisms forward and have further accelerated translational research. Additionally, expanding government and private funding, along with collaborative research initiatives, are fueling innovation in brain research, neurotechnology, and cognitive health solutions.

The market also offers opportunities for the development of personalized medicine, early diagnostic tools for cognitive disorders, and neuro-enhancement applications. Some of the key players operating in the global cognitive neuroscience market are Siemens Healthineers, GE Healthcare, Philips Healthcare, Hitachi Medical Systems, and Compumedics Limited. These firms are further investing in advanced imaging systems, AI-driven platforms, and digital solutions to enhance their presence in this emerging field.  On January 9, 2024, the European Commission decided to grant €38 million to finance EBRAINS until 2026. As a legacy from the Human Brain Project, EBRAINS is an EU-cofunded digital research infrastructure to advance neuroscience, brain medicine, and brain-inspired technologies by providing tools and services that bring together researchers and clinicians to explore brain complexity and develop innovative solutions.

Report Coverage

This research report categorizes the cognitive neuroscience market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the cognitive neuroscience market. Recent market developments and competitive strategies, such as expansion, type launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the cognitive neuroscience market. 

Driving Factors

The global cognitive neuroscience market is driven by growing demand for advanced brain imaging technologies, an increase in the prevalence of neurological and psychiatric disorders, and rising investment in neuroscience research. Technological advances in neuroimaging, such as MRI, PET, and EEG, further improve knowledge of the functionality of the brain and cognitive processes. The expanding use of neuroimaging in diagnosing neurodegenerative diseases and the development of brain-computer interfaces ensure further growth of the market. Apart from these factors, government and private funding for neuroscience initiatives, increasing use of AI in data analysis, and interest in personalized medicine add to this market's growth by spurring innovation in diagnostics, therapeutics, and cognitive enhancement tools.

Restraining Factors

Some of the factors restraining the growth of the cognitive neuroscience market include high costs related to neuroimaging equipment and research, limited accessibility in developing regions, ethical concerns regarding brain data privacy, a shortage of skilled professionals, complex regulatory approvals, and variability in neuroimaging results that impede the wide-scale adoption and commercialization of technologies within cognitive neuroscience.

Market Segmentation

The cognitive neuroscience market share is classified into type, application, and end user.

• The magnetic resonance imaging (MRI) segment dominated the market in 2024, approximately 35% and is projected to grow at a substantial CAGR during the forecast period.

Based on the type, the cognitive neuroscience market is divided into magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), positron emission tomography (PET), magnetoencephalography (MEG), encephalography (EEC), near infrared spectroscopy (NIRS) and single photon emission computed tomography (SPECT). Among these, the magnetic resonance imaging (MRI) segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. The MRI segment dominated the growth in the global cognitive neuroscience market, as it provides superior imaging, is non-invasive, and there is also an increasing demand for early and accurate diagnosis of diseases. This is further propelled by the increasing prevalence of chronic diseases, advancements in MRI systems, and growing awareness about preventive health. Furthermore, rapidly growing healthcare infrastructure and government initiatives to enhance diagnostic facilities in emerging markets.

• The brain imaging segment accounted for the largest share in 2024, approximately 36% and is anticipated to grow at a significant CAGR during the forecast period.

Based on the application, the cognitive neuroscience market is divided into brain imaging, neurological research, neurological disorders and psychiatry. Among these, the brain imaging segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.  Growth in the brain imaging segment is facilitated by increasing demand for advanced neuroimaging techniques, including MRI, fMRI, PET, and MEG, to study brain structure and function. Other factors that have driven market growth include the increasing prevalence of neurological and psychiatric disorders, expanding research initiatives, and technological innovation in imaging tools.

• The academic research institutes segment accounted for the highest market revenue in 2024, approximately 42% and is anticipated to grow at a significant CAGR during the forecast period.

Based on the end user, the cognitive neuroscience market is divided into pharmaceutical companies, clinical & research laboratories, academic research institutes, hospitals & pathology laboratories and others. Among these, the academic research institutes segment accounted for the highest market revenue in 2024 and is anticipated to grow at a significant CAGR during the forecast period. Growth in the academic research institutes segment is driven by growing investments in neuroscience research, government and private funding available to support research in universities and research centers, and the widespread use of advanced neuroimaging and brain-mapping technologies in universities and research institutes. Besides, collaborations with pharmaceutical companies and hospitals to perform translational studies further enhance the demand for cognitive neuroscience tools and services.

Regional Segment Analysis of the Cognitive Neuroscience Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the cognitive neuroscience market over the predicted timeframe.

accounting for around 48% of the total market. This dominance is attributed to its strong healthcare infrastructure, significant funding for research from both government and private agencies, and the widespread adoption of advanced neuroimaging technologies such as MRI, fMRI, PET, and MEG. The United States leads the region with major national initiatives, including the NIH BRAIN Initiative, and extensive university-hospital collaborations that support neuroscience research and cognitive disorder studies. Canada also contributes to this growth through programs such as Brain Canada's Platform Support Grants, further strengthening the region’s leadership in research, innovation, and clinical applications.

In May 2024, NIH BRAIN Initiative’s BRAIN CONNECTS researchers created the highest resolution 3D map of human brain tissue at the subcellular level. Using electron microscopy and AI, they imaged a cubic millimetre, about half a grain of rice, revealing intricate structures within and around brain cells, advancing understanding of neural connectivity and brain organization.

Asia Pacific is expected to grow at a rapid CAGR in the cognitive neuroscience market during the forecast period. The Asia Pacific region is rapidly growing in the cognitive neuroscience market, with an approximate 22% market share, owing to increasing government investments in healthcare and neuroscience studies, the rising burden of neurological disorders, and the growing penetration of advanced neuroimaging technologies. Large countries such as China and India are driving growth, underpinned by national brain research initiatives and collaborations with globally renowned research institutions. Moreover, a surge in the geriatric population and an increase in clinical and academic research infrastructure in the region accelerate the demand for tools and diagnostic solutions in cognitive neuroscience.

Europe’s cognitive neuroscience market growth is driven by its ageing population, increasing prevalence of neurological and psychiatric disorders, and robust public and private sector funding for brain research. Advanced health infrastructure in countries such as Germany and the UK enables the fast diffusion of neuroimaging and neurotechnology. Moreover, pan-European programs such as Horizon Europe and research infrastructure platforms, such as EBRAINS AISBL, also support innovation, collaboration, and commercialization in cognitive neuroscience.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the cognitive neuroscience market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Siemens Healthineers
• Medtronic
• GE Healthcare
• Blackrock Neurotech
• Philips Healthcare
• NeuroPace
• Boston Scientific
• Neuralink
• Compumedics Limited
• Alpha Omega Inc.
• EMOTIV
• Cadwell Industries Inc.
• ANT Neuro
• Brain Products GmbH
• Nihon Kohden Corporation
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs) 

Recent Development

• In October 2025, Medtronic announced that its BrainSense Adaptive Deep Brain Stimulation (aDBS) system, the world’s first closed-loop DBS for Parkinson’s patients, was recognized by TIME on its annual Best Inventions list, highlighting its innovation in healthcare technology and neurological treatment.

• In September 2025, GE HealthCare announced its agreement to acquire icometrix, a company specializing in AI-powered brain imaging analysis for neurological disorders such as Alzheimer’s, aiming to enhance MRI capabilities and support personalized treatment planning amid growing demand for advanced neuroimaging solutions.

• In May 2025, Cognixion announced that Blackrock Neurotech will distribute its Axon-R wearable neural interface platform to research institutions. Combining non-invasive BCI, AI, and AR technologies, this partnership expands access to advanced neural interfaces for scientific research and cognitive neuroscience applications.

• In February 2025, Medtronic announced FDA approval of BrainSense Adaptive DBS and BrainSense Electrode Identifier for Parkinson’s disease in the U.S., benefiting the one million patients diagnosed with the condition and advancing personalized, innovative neuromodulation therapy.

• In January 2025, Neuro XR (NXR) and Emotiv launched Emotional Heatmapping Technology, combining NXR’s analytics software with Emotiv’s EEG devices. The collaboration enables real-time emotional and behavioural analysis, providing valuable insights into user engagement and transforming cognitive and affective neuroscience research.

• In January 2025, Siemens Healthineers showcased its diagnostic imaging solutions at AOCR 2025 in Chennai, presenting innovations in MRI, CT, digital X-ray, and ultrasound. Emphasizing informed clinical decision-making and precision medicine, the demonstration reinforced the company’s commitment to advancing healthcare across the entire patient care continuum.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the cognitive neuroscience market based on the below-mentioned segments:  

Global Cognitive Neuroscience Market, By Type

• Magnetic Resonance Imaging (MRI)
• Functional Magnetic Resonance Imaging (fMRI)
• Positron Emission Tomography (PET)
• Magnetoencephalography (MEG)
• Encephalography (EEC)
• Near Infrared Spectroscopy (NIRS)
• Single Photon Emission Computed Tomography (SPECT)

Global Cognitive Neuroscience Market, By Application

• Brain Imaging
• Neurological Research
• Neurological Disorders
• Psychiatry

Global Cognitive Neuroscience Market, By End User

• Pharmaceutical Companies
• Clinical & Research Laboratories
• Academic Research Institutes
• Hospitals & Pathology Laboratories
• Others

Global Cognitive Neuroscience Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa